Skip to main content
NCBI home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1986 Jun;144(6):710–721.

Short Stature—Physiology and Pathology

David L Rimoin 1,2, Zvi Borochowitz 1,2, William A Horton 1,2
PMCID: PMC1306754  PMID: 2873688

Abstract

Stature, the quantitative measure of height, varies widely within each ethnic group with a fairly normal distribution. Of the numerous patients whom physicians encounter because of short stature, relatively few are pathologically small in the context of family and ethnic background. Physicians must be able to differentiate pathologic short stature from the lower end of the normal curve before embarking on a complex diagnostic evaluation. There are literally hundreds of different causes of short stature, and the clinical evaluation requires a wide variety of clinical, radiographic, pathologic and biochemical tools. Although specific treatment to promote growth is available only in persons with the endocrinopathies and the acquired nutritional, emotional and chronic disease states, diagnosis of the specific form of short stature can have great importance in being able to prevent complications and to offer accurate prognostic information and genetic counseling.

Full text

PDF
710

Images in this article

712Figure 2.
on p.712
714Figure 3.
on p.714

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aarskog D., Fevang F. O., Klove H., Stoa K. F., Thorsen T. The effect of the stimulant drugs, dextroamphetamine and methylphenidate, on secretion of growth hormone in hyperactive children. J Pediatr. 1977 Jan;90(1):136–139. doi: 10.1016/s0022-3476(77)80788-9. [DOI] [PubMed] [Google Scholar]
  2. BAYLEY N., PINNEAU S. R. Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards. J Pediatr. 1952 Apr;40(4):423–441. doi: 10.1016/s0022-3476(52)80205-7. [DOI] [PubMed] [Google Scholar]
  3. Berelowitz M., Szabo M., Frohman L. A., Firestone S., Chu L., Hintz R. L. Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary. Science. 1981 Jun 12;212(4500):1279–1281. doi: 10.1126/science.6262917. [DOI] [PubMed] [Google Scholar]
  4. Bierich J. R., Moeller H., Ranke M. B., Rosenfeld R. G. Pseudopituitary dwarfism due to resistance to somatomedin: a new syndrome. Eur J Pediatr. 1984 Aug;142(3):186–188. doi: 10.1007/BF00442446. [DOI] [PubMed] [Google Scholar]
  5. Fleisher T. A., White R. M., Broder S., Nissley S. P., Blaese R. M., Mulvihill J. J., Olive G., Waldmann T. A. X-linked hypogammaglobulinemia and isolated growth hormone deficiency. N Engl J Med. 1980 Jun 26;302(26):1429–1434. doi: 10.1056/NEJM198006263022601. [DOI] [PubMed] [Google Scholar]
  6. Frasier S. D. Growth disorders in children. Pediatr Clin North Am. 1979 Feb;26(1):1–14. doi: 10.1016/s0031-3955(16)33668-9. [DOI] [PubMed] [Google Scholar]
  7. Golde D. W., Bersch N., Kaplan S. A., Rimoin D. L., Li C. H. Peripheral unresponsiveness to human growth hormone in Laron dwarfism. N Engl J Med. 1980 Nov 13;303(20):1156–1159. doi: 10.1056/NEJM198011133032006. [DOI] [PubMed] [Google Scholar]
  8. Isaksson O. G., Jansson J. O., Gause I. A. Growth hormone stimulates longitudinal bone growth directly. Science. 1982 Jun 11;216(4551):1237–1239. doi: 10.1126/science.7079756. [DOI] [PubMed] [Google Scholar]
  9. Klapper D. G., Svoboda M. E., Van Wyk J. J. Sequence analysis of somatomedin-C: confirmation of identity with insulin-like growth factor I. Endocrinology. 1983 Jun;112(6):2215–2217. doi: 10.1210/endo-112-6-2215. [DOI] [PubMed] [Google Scholar]
  10. Lanes R., Plotnick L. P., Spencer E. M., Daughaday W. H., Kowarski A. A. Dwarfism associated with normal serum growth hormone and increased bioassayable, receptorassayable, and immunoassayable somatomedin. J Clin Endocrinol Metab. 1980 Mar;50(3):485–488. doi: 10.1210/jcem-50-3-485. [DOI] [PubMed] [Google Scholar]
  11. Laron Z., Kowadlo-Silbergeld A., Eshet R., Pertzelan A. Growth hormone resistance. Ann Clin Res. 1980 Oct;12(5):269–277. [PubMed] [Google Scholar]
  12. Martin J. B. Functions of central nervous system neurotransmitters in regulation of growth hormone secretion. Fed Proc. 1980 Sep;39(11):2902–2906. [PubMed] [Google Scholar]
  13. Merimee T. J., Zapf J., Froesch E. R. Insulin-like growth factors (IGFs) in pygmies and subjects with the pygmy trait: characterization of the metabolic actions of IGF I and IGF II in man. J Clin Endocrinol Metab. 1982 Dec;55(6):1081–1088. doi: 10.1210/jcem-55-6-1081. [DOI] [PubMed] [Google Scholar]
  14. Miller W. L., Eberhardt N. L. Structure and evolution of the growth hormone gene family. Endocr Rev. 1983 Spring;4(2):97–130. doi: 10.1210/edrv-4-2-97. [DOI] [PubMed] [Google Scholar]
  15. Owerbach D., Rutter W. J., Martial J. A., Baxter J. D., Shows T. B. Genes for growth hormone, chorionic somatommammotropin, and growth hormones-like gene on chromosome 17 in humans. Science. 1980 Jul 11;209(4453):289–292. doi: 10.1126/science.7384802. [DOI] [PubMed] [Google Scholar]
  16. Phillips J. A., 3rd, Hjelle B. L., Seeburg P. H., Zachmann M. Molecular basis for familial isolated growth hormone deficiency. Proc Natl Acad Sci U S A. 1981 Oct;78(10):6372–6375. doi: 10.1073/pnas.78.10.6372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Phillips J. A., 3rd, Parks J. S., Hjelle B. L., Herd J. E., Plotnick L. P., Migeon C. J., Seeburg P. H. Genetic analysis of familial isolated growth hormone deficiency type I. J Clin Invest. 1982 Sep;70(3):489–495. doi: 10.1172/JCI110640. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Phillips L. S., Vassilopoulou-Sellin R. Somatomedins (second of two parts). N Engl J Med. 1980 Feb 21;302(8):438–446. doi: 10.1056/NEJM198002213020805. [DOI] [PubMed] [Google Scholar]
  19. Plotnick L. P., Van Meter Q. L., Kowarski A. A. Human growth hormone treatment of children with growth failure and normal growth hormone levels by immunoassay: lack of correlation with somatomedin generation. Pediatrics. 1983 Mar;71(3):324–327. [PubMed] [Google Scholar]
  20. Powell G. F., Brasel J. A., Blizzard R. M. Emotional deprivation and growth retardation simulating idiopathic hypopituitarism. I. Clinical evaluation of the syndrome. N Engl J Med. 1967 Jun 8;276(23):1271–1278. doi: 10.1056/NEJM196706082762301. [DOI] [PubMed] [Google Scholar]
  21. Prockop D. J. Mutations in collagen genes. Consequences for rare and common diseases. J Clin Invest. 1985 Mar;75(3):783–787. doi: 10.1172/JCI111773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Rimoin D. L., Horton W. A. Short stature. Part I. J Pediatr. 1978 Apr;92(4):523–528. doi: 10.1016/s0022-3476(78)80281-9. [DOI] [PubMed] [Google Scholar]
  23. Rivarola M. A., Phillips J. A., 3rd, Migeon C. J., Heinrich J. J., Hjelle B. J. Phenotypic heterogeneity in familial isolated growth hormone deficiency type I-A. J Clin Endocrinol Metab. 1984 Jul;59(1):34–40. doi: 10.1210/jcem-59-1-34. [DOI] [PubMed] [Google Scholar]
  24. Roche A. F., Lipman R. S., Overall J. E., Hung W. The effects of stimulant medication on the growth of hyperkinetic children. Pediatrics. 1979 Jun;63(6):847–850. [PubMed] [Google Scholar]
  25. Rudman D., Kutner M. H., Blackston R. D., Cushman R. A., Bain R. P., Patterson J. H. Children with normal-variant short stature: treatment with human growth hormone for six months. N Engl J Med. 1981 Jul 16;305(3):123–131. doi: 10.1056/NEJM198107163050302. [DOI] [PubMed] [Google Scholar]
  26. Schechter J., Kovacs K., Rimoin D. Isolated growth hormone deficiency: immunocytochemistry. J Clin Endocrinol Metab. 1984 Oct;59(4):798–800. doi: 10.1210/jcem-59-4-798. [DOI] [PubMed] [Google Scholar]
  27. Schoenle E., Zapf J., Humbel R. E., Froesch E. R. Insulin-like growth factor I stimulates growth in hypophysectomized rats. Nature. 1982 Mar 18;296(5854):252–253. doi: 10.1038/296252a0. [DOI] [PubMed] [Google Scholar]
  28. Sillence D. O., Horton W. A., Rimoin D. L. Morphologic studies in the skeletal dysplasias. Am J Pathol. 1979 Sep;96(3):813–870. [PMC free article] [PubMed] [Google Scholar]
  29. Smith D. W., Truog W., Rogers J. E., Greitzer L. J., Skinner A. L., McCann J. J., Harvey M. A. Shifting linear growth during infancy: illustration of genetic factors in growth from fetal life through infancy. J Pediatr. 1976 Aug;89(2):225–230. doi: 10.1016/s0022-3476(76)80453-2. [DOI] [PubMed] [Google Scholar]
  30. Tanner J. M. Charts for the diagnosis of short stature and low growth velocity, allowance for height of parents and prediction of adult height. Birth Defects Orig Artic Ser. 1976;12(6):1–13. [PubMed] [Google Scholar]
  31. Tanner J. M., Whitehouse R. H., Takaishi M. Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. I. Arch Dis Child. 1966 Oct;41(219):454–471. doi: 10.1136/adc.41.219.454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Valenta L. J., Sigel M. B., Lesniak M. A., Elias A. N., Lewis U. J., Friesen H. G., Kershnar A. K. Pituitary dwarfism in a patient with circulating abnormal growth hormone polymers. N Engl J Med. 1985 Jan 24;312(4):214–217. doi: 10.1056/NEJM198501243120405. [DOI] [PubMed] [Google Scholar]
  33. Zachmann M. Diagnosis of treatable types of short and tall stature. Postgrad Med J. 1978;54 (Suppl 1):121–132. [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES